+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceuticals Market Research Reports

Regenerative Medicine - Global Strategic Business Report - Product Thumbnail Image

Regenerative Medicine - Global Strategic Business Report

  • Report
  • June 2025
  • 198 Pages
  • Global
From
From
Hollow Fiber Filtration - Global Strategic Business Report - Product Thumbnail Image

Hollow Fiber Filtration - Global Strategic Business Report

  • Report
  • June 2025
  • 244 Pages
  • Global
From
Vaccine Adjuvants - Global Strategic Business Report - Product Thumbnail Image

Vaccine Adjuvants - Global Strategic Business Report

  • Report
  • June 2025
  • 193 Pages
  • Global
From
From
Biologics Safety Testing - Global Strategic Business Report - Product Thumbnail Image

Biologics Safety Testing - Global Strategic Business Report

  • Report
  • June 2025
  • 182 Pages
  • Global
From
Dengue Vaccine - Global Strategic Business Report - Product Thumbnail Image

Dengue Vaccine - Global Strategic Business Report

  • Report
  • June 2025
  • 193 Pages
  • Global
From
Meningococcal Vaccines - Global Strategic Business Report - Product Thumbnail Image

Meningococcal Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 194 Pages
  • Global
From
From
Biologics - Global Strategic Business Report - Product Thumbnail Image

Biologics - Global Strategic Business Report

  • Report
  • June 2025
  • 293 Pages
  • Global
From
From
Peptide Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peptide Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 192 Pages
  • Global
From
Microbiome Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Microbiome Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 196 Pages
  • Global
From
Protein Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Protein Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 181 Pages
  • Global
From
Biological Drugs - Global Strategic Business Report - Product Thumbnail Image

Biological Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 196 Pages
  • Global
From
Human Vaccines - Global Strategic Business Report - Product Thumbnail Image

Human Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 262 Pages
  • Global
From
Human Microbiome - Global Strategic Business Report - Product Thumbnail Image

Human Microbiome - Global Strategic Business Report

  • Report
  • June 2025
  • 183 Pages
  • Global
From
Anti Venoms - Global Strategic Business Report - Product Thumbnail Image

Anti Venoms - Global Strategic Business Report

  • Report
  • June 2025
  • 196 Pages
  • Global
From
Monoclonal Antibodies - Global Strategic Business Report - Product Thumbnail Image

Monoclonal Antibodies - Global Strategic Business Report

  • Report
  • June 2025
  • 213 Pages
  • Global
From
Biosimilars - Global Strategic Business Report - Product Thumbnail Image

Biosimilars - Global Strategic Business Report

  • Report
  • June 2025
  • 193 Pages
  • Global
From
Loading Indicator

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more